Is a single COVID-19 vaccine dose enough in convalescents ?
SARS-CoV-2 has infected more than 122 million persons worldwide. Most currently licensed COVID-19 vaccines require a two-dose course and many health systems are on a shortage of doses. The requirement for boosting the response after priming with the first dose is uncertain in convalescents already p...
| Published in: | Human Vaccines & Immunotherapeutics |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-09-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1917238 |